메뉴 건너뛰기
Lancet
Volumn 369, Issue 9574, 2007, Pages 1668-1670
Ovarian suppression for early breast cancer
Author keywords

[No Author keywords available]
Indexed keywords

GONADORELIN;
EID: 34248532151     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60758-2     Document Type: Note
Times cited : (2)
References (8)
  • 1
    • 50549123220 scopus 로고
    • On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases
    • Beatson G. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Lancet 148 (1896) 104-107
    • (1896) Lancet , vol.148 , pp. 104-107
    • Beatson, G.1
  • 2
    • 34248574344 scopus 로고    scopus 로고
    • Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials
    • LHRH-agonists in Early Breast Cancer Overview group
    • LHRH-agonists in Early Breast Cancer Overview group. Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials. Lancet 369 (2007) 1711-1723
    • (2007) Lancet , vol.369 , pp. 1711-1723
  • 3
    • 19344364880 scopus 로고    scopus 로고
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
    • Early Breast Cancer Trialists' Collaborative Group
    • Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365 (2005) 1687-1717
    • (2005) Lancet , vol.365 , pp. 1687-1717
  • 4
    • 15544381255 scopus 로고    scopus 로고
    • Adjuvant endocrine therapy for premenopausal women with early breast cancer
    • Dellapasqua S., Colleoni M., Gelber R., and Goldhirsch A. Adjuvant endocrine therapy for premenopausal women with early breast cancer. J Clin Oncol 23 (2005) 1736-1750
    • (2005) J Clin Oncol , vol.23 , pp. 1736-1750
    • Dellapasqua, S.1    Colleoni, M.2    Gelber, R.3    Goldhirsch, A.4
  • 5
    • 22944448403 scopus 로고    scopus 로고
    • What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?
    • Thewes B., Meiser B., Duric V., et al. What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?. Lancet Oncol 6 (2005) 581-588
    • (2005) Lancet Oncol , vol.6 , pp. 581-588
    • Thewes, B.1    Meiser, B.2    Duric, V.3
  • 6
    • 28644436115 scopus 로고    scopus 로고
    • Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile?
    • Duric V., Fallowfield L., Saunders C., Houghton J., Coates A., and Stockler M. Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile?. Br J Cancer 93 (2005) 1319-1323
    • (2005) Br J Cancer , vol.93 , pp. 1319-1323
    • Duric, V.1    Fallowfield, L.2    Saunders, C.3    Houghton, J.4    Coates, A.5    Stockler, M.6
  • 7
    • 27744593114 scopus 로고    scopus 로고
    • Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?
    • Duric V., Stockler M., Heritier S., et al. Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?. Ann Oncol 16 (2005) 1786-1794
    • (2005) Ann Oncol , vol.16 , pp. 1786-1794
    • Duric, V.1    Stockler, M.2    Heritier, S.3
  • 8
    • 7444259675 scopus 로고    scopus 로고
    • A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
    • Goss P., Ingle J., Martino S., et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349 (2003) 1793-1802
    • (2003) N Engl J Med , vol.349 , pp. 1793-1802
    • Goss, P.1    Ingle, J.2    Martino, S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.